VIR - Vir Biotechnology, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	#f	T	TVal	Price	Qty	Own	H
3/3/26 12:10	3/2/26	VIR	Health	BioPrd	Biological Products, (No Diag	Sato Vicki L	CA	D		11	S.d	-1,776	7.07	-251	1,312	D
2/26/26 16:56	2/24/26	VIR	Health	BioPrd	Biological Products, (No Diag	Sabatini Brent	CA	O	SVP, Chi	5	S.d	-68	8.62	-8	71	D
2/26/26 16:55	2/24/26	VIR	Health	BioPrd	Biological Products, (No Diag	O'Byrne Jason	CA	O	EVP,CFO	3	S.d	-69	6.55	-11	164	D
2/26/26 16:55	2/24/26	VIR	Health	BioPrd	Biological Products, (No Diag	Eisner Mark	CA	O	EVP,Chie	3	S.dm	-106	6.65	-16	158	D
2/26/26 16:54	2/24/26	VIR	Health	BioPrd	Biological Products, (No Diag	De Verneuil Vanina	CA	O	EVP,GC,C	9	S.dm	-411	8.99	-46	130	D
2/26/26 16:54	2/24/26	VIR	Health	BioPrd	Biological Products, (No Diag	De Backer Marianne	CA	DO	CEO	4	S.d	-909	7.01	-130	1,089	D
12/3/25 16:30	12/1/25	VIR	Health	BioPrd	Biological Products, (No Diag	Svf Endurance (Cayman) Ltd	E9	T		11	S.m	-17,848	6.04	-2,955	16,160	I
6/2/25 19:26	6/2/25	VIR	Health	BioPrd	Biological Products, (No Diag	Napolitano Janet	CA	D		1	S.d	-16	5.05	-3	16	D
2/25/25 15:44	2/24/25	VIR	Health	BioPrd	Biological Products, (No Diag	Scangos George A	CA	D		2	S	-203	9.64	-21	3,824	D
2/25/25 15:43	2/24/25	VIR	Health	BioPrd	Biological Products, (No Diag	Hanly Ann M.	CA	O	EVP,CTO	1	S	-134	9.45	-14	118	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person